MX340956B - Vectores baculovirales. - Google Patents

Vectores baculovirales.

Info

Publication number
MX340956B
MX340956B MX2013008741A MX2013008741A MX340956B MX 340956 B MX340956 B MX 340956B MX 2013008741 A MX2013008741 A MX 2013008741A MX 2013008741 A MX2013008741 A MX 2013008741A MX 340956 B MX340956 B MX 340956B
Authority
MX
Mexico
Prior art keywords
transfer vector
gene
relates
present
baculoviral vectors
Prior art date
Application number
MX2013008741A
Other languages
English (en)
Inventor
Robert James Noad
Polly Roy
Original Assignee
London School Of Hygiene & Tropical Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by London School Of Hygiene & Tropical Medicine filed Critical London School Of Hygiene & Tropical Medicine
Publication of MX340956B publication Critical patent/MX340956B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vectore
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14051—Methods of production or purification of viral material
    • C12N2710/14052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La presente invención se refiere a un vector de transferencia para la inserción de un gen en un locus genético de una secuencia de baculovirus; el vector de transferencia comprende un cassette de expresión que comprende un promotor eucariótico enlazado operablemente al gen y un cassette de selección bipartita; la presente invención se refiere también a métodos de uso del vector de transferencia y bácmidos y baculovirus derivados.
MX2013008741A 2008-11-11 2009-11-11 Vectores baculovirales. MX340956B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0820631.0A GB0820631D0 (en) 2008-11-11 2008-11-11 Vectors
PCT/GB2009/002647 WO2010055292A2 (en) 2008-11-11 2009-11-11 Vectors

Publications (1)

Publication Number Publication Date
MX340956B true MX340956B (es) 2016-07-29

Family

ID=40139744

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2013008741A MX340956B (es) 2008-11-11 2009-11-11 Vectores baculovirales.
MX2011004902A MX2011004902A (es) 2008-11-11 2009-11-11 Vectores baculovirales.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2011004902A MX2011004902A (es) 2008-11-11 2009-11-11 Vectores baculovirales.

Country Status (20)

Country Link
US (2) US9212374B2 (es)
EP (1) EP2358883B1 (es)
JP (2) JP5986381B2 (es)
KR (1) KR20110089420A (es)
CN (2) CN102245777B (es)
AU (1) AU2009315471B2 (es)
BR (1) BRPI0921907A2 (es)
CA (1) CA2740714A1 (es)
CL (2) CL2011001056A1 (es)
CO (1) CO6420360A2 (es)
ES (1) ES2616855T3 (es)
GB (1) GB0820631D0 (es)
MX (2) MX340956B (es)
MY (1) MY178947A (es)
PH (1) PH12014501252A1 (es)
RU (2) RU2014145441A (es)
SG (1) SG10201509570TA (es)
UA (1) UA106733C2 (es)
WO (1) WO2010055292A2 (es)
ZA (2) ZA201103286B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0820631D0 (en) 2008-11-11 2008-12-17 London School Hygiene & Tropical Medicine Vectors
JP6010545B2 (ja) 2010-12-23 2016-10-19 トゥエルヴ， インコーポレイテッド 僧帽弁の修復および置換のためのシステム
FR2978456B1 (fr) 2011-07-27 2015-02-20 Genethon Systeme baculoviral pour l'expression d'un vecteur de therapie genique
GB201309132D0 (en) * 2013-05-21 2013-07-03 Biosyntia Aps Regulatable gene expression
WO2016204644A1 (ru) * 2015-06-19 2016-12-22 Общество С Ограниченной Ответственностью "Панацела Лабс" Способ производства препарата на основе нереплицирующегося вирусного вектора, экспрессирующего ген человеческого toll-подобного рецептора и ген модифицированного белка флагеллина
FR3054841B1 (fr) * 2016-08-05 2021-01-29 Centre Nat Rech Scient Systeme d'expression baculovirus
FR3072686B1 (fr) * 2017-10-25 2021-10-22 Centre Nat Rech Scient Systeme d'expression baculovirus
CN109609552B (zh) * 2018-12-28 2020-04-14 中国科学院武汉物理与数学研究所 重组腺相关病毒的制备方法、系统及重组杆粒
US11708585B2 (en) * 2018-12-28 2023-07-25 Wuhan Institute Of Physics And Mathematics, Chinese Academy Of Sciences Method, system and recombinant bacmid for preparation of recombinant adeno-associated virus
CN114369624B (zh) * 2021-12-30 2023-07-14 华南农业大学 一种降低病毒感染导致的昆虫细胞凋亡的方法
CN118086400A (zh) * 2024-04-17 2024-05-28 和元生物技术（上海）股份有限公司 核酸分子、包含其的重组杆状病毒及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1257184B (it) * 1992-12-22 1996-01-10 Applied Research Systems Preparato ad attivita' antinfiammatoria, anticoagulante e antitumorale
KR20000048845A (ko) * 1996-10-01 2000-07-25 쥬디 씨. 버틀러 곤충-특이적 진드기 독소 유전자를 발현하는 생물학적 곤충방제제, 방법 및 조성물
US6054312A (en) * 1997-08-29 2000-04-25 Selective Genetics, Inc. Receptor-mediated gene delivery using bacteriophage vectors
EP0999284A1 (en) * 1998-09-11 2000-05-10 Hoechst Marion Roussel Method for screening antimycotic substances using essential genes from c.albicans, and said genes
EP1293564A4 (en) * 2000-06-08 2005-08-17 Mitsubishi Pharma Corp EXPRESSION VECTOR FOR SCREENING CELLS HIGH EXPRESSION OF RECOMBINANT PROTEINS, TRANSFORMING HIGH EXPRESSION OF A RECOMBINANT PROTEIN AND USE THEREOF
US6551828B1 (en) 2000-06-28 2003-04-22 Protemation, Inc. Compositions and methods for generating expression vectors through site-specific recombination
JP4024525B2 (ja) * 2001-11-21 2007-12-19 独立行政法人科学技術振興機構 異なる２つの選択マーカーからなる融合タンパク質
WO2003074714A1 (en) 2002-03-05 2003-09-12 Stichting Voor De Technische Wetenschappen Baculovirus expression system
IL164687A0 (en) * 2002-05-02 2005-12-18 Univ North Carolina Cellular libraries and methods for the preparationthereof
MXPA05003382A (es) * 2002-10-04 2005-06-22 Du Pont Proceso para la produccion biologica de 1,3-propanodiol con alto rendimiento.
EP1723246B1 (en) * 2004-03-09 2009-09-09 Eidgenössische Technische Hochschule Zürich New expression tools for multiprotein applications
FR2877013A1 (fr) * 2004-10-27 2006-04-28 Assist Publ Hopitaux De Paris Indentification d'une mutation de jak2 impliquee dans la polyglobulie de vaquez
EP1783228A1 (en) * 2005-11-08 2007-05-09 ETH Zürich Recombinant expression of multiprotein complexes using polygenes
GB0605265D0 (en) * 2006-03-15 2006-04-26 London School Hygiene & Tropical Medicine Virus-like particles of rift valley fever virus
GB0820631D0 (en) 2008-11-11 2008-12-17 London School Hygiene & Tropical Medicine Vectors

Also Published As

Publication number Publication date
CL2011001056A1 (es) 2011-10-14
GB0820631D0 (en) 2008-12-17
CO6420360A2 (es) 2012-04-16
US20110281261A1 (en) 2011-11-17
RU2014145441A (ru) 2015-06-20
ES2616855T3 (es) 2017-06-14
ZA201203945B (en) 2013-01-31
CL2015000113A1 (es) 2015-06-19
EP2358883B1 (en) 2016-12-07
JP2012508004A (ja) 2012-04-05
ZA201103286B (en) 2012-10-31
PH12014501252A1 (en) 2015-10-05
UA106733C2 (uk) 2014-10-10
US20160090575A1 (en) 2016-03-31
CN102245777B (zh) 2016-05-11
RU2011114814A (ru) 2012-12-20
KR20110089420A (ko) 2011-08-08
AU2009315471A1 (en) 2010-05-20
CA2740714A1 (en) 2010-05-20
WO2010055292A3 (en) 2010-08-26
US9777260B2 (en) 2017-10-03
SG10201509570TA (en) 2015-12-30
CN102245777A (zh) 2011-11-16
BRPI0921907A2 (pt) 2015-08-25
MX2011004902A (es) 2011-06-16
US9212374B2 (en) 2015-12-15
JP5986381B2 (ja) 2016-09-06
AU2009315471B2 (en) 2014-07-10
CN105400818A (zh) 2016-03-16
MY178947A (en) 2020-10-23
WO2010055292A2 (en) 2010-05-20
EP2358883A2 (en) 2011-08-24
RU2569183C2 (ru) 2015-11-20
JP2016101164A (ja) 2016-06-02

Similar Documents

Publication Publication Date Title
MX340956B (es) Vectores baculovirales.
AU2009223508A8 (en) Expression of catalase in Trichoderma
WO2007095496A3 (en) Selecting and stabilizing dsrna constructs
IL181340A0 (en) Isolation of stem/progenitor cells from amniotic membrane of umbilical cord
MX352023B (es) Variantes de alfa-amilasa con estabilidad mejorada.
MY146612A (en) Production of isoprenoids
MX2009008877A (es) Variantes de transglutaminasa con especificidad mejorada.
WO2012071318A3 (en) Subfamily e simian adenoviruses a1321, a1325, a1295, a1309, a1316 and a1322 and uses thereof
SG162726A1 (en) Gene vector comprising mi-rna
WO2010051049A3 (en) Thermophilic and thermoacidophilic glycosylation genes and enzymes from alicyclobacillus acidocaldarius and related organisms, methods
EP2245143A4 (en) THERMOPHILIC AND THERMOACIDOPHILIC ACID CHALK AND ENZYMES FROM ALICYCLOBACILLUS ACIDOCALDARIUS AND CORRESPONDING ORGANISMS AND METHODS
MX2011006301A (es) Produccion de alcoholes de cadena ramificada por medio de microorganismos fotosinteticos.
IL201963A0 (en) Vectors for multiple gene expression
WO2008146745A1 (ja) 新規なリゾホスファチジン酸アシル基転移酵素遺伝子
EP1981331A4 (en) IMPROVEMENT OF EXPRESSION OF ADDED GENES BY TRANSGENIC EXPRESSION OF TOMBUSVIRUS-BASED P19 GENE MUTANTS
IN2014MN00246A (es)
WO2010140862A3 (ko) 단일 또는 멀티 표적 유전자를 억제하는 멀티-시스트로닉 ｓｈＲＮＡ 발현 카세트
WO2008112226A3 (en) Cre-lox based gene knockdown constructs and methods of use thereof
WO2009069986A3 (en) Genetically-modified cell line for producing cloned miniature pigs for xenotransplantation and method for preparing the same.
MX2010009071A (es) Peptidos aislados que tienen actividad inhibitoria de fosfolipasa.
WO2010003103A3 (en) Non-human mammals with t or b cells having predefined specificity
WO2011006145A3 (en) Compositions and methods for mammalian genetics and uses thereof
MX2010013183A (es) Variantes de xiloglucanasa de la familia 44.
ATE532861T1 (de) Expressionsvektor
WO2010056816A3 (en) βGI-IGG INTRON FOR ENHANCED ANTI-IGF1 R EXPRESSION